GO:0032655 regulation of interleukin-12 production: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032655 describes any process that modulates the frequency, rate, or extent of interleukin-12 (IL-12) production, a central cytokine in T-helper 1 (Th1) immunity.
• IL-12 production is primarily regulated in antigen-presenting cells such as dendritic cells, macrophages, and monocytes in response to microbial stimuli.
• Positive regulators include pattern recognition receptors (TLRs, CR3), CD40 signaling, and IFN-gamma, while negative regulators include IL-10, TGF-beta, and SOCS1.
• Differential regulation of IL-12 and IL-23 is critical for shaping Th1 versus Th17 responses in humans.
• Dysregulated IL-12 production is implicated in autoimmune diseases, chronic infections, and cancer immunosurveillance.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of genes controlling IL-12 production.
Description
Interleukin-12 (IL-12) is a heterodimeric cytokine composed of p35 and p40 subunits that bridges innate and adaptive immunity by inducing IFN-gamma production and Th1 differentiation. The Gene Ontology term GO:0032655, regulation of interleukin-12 production, encompasses all biological processes that modulate the frequency, rate, or extent of IL-12 synthesis and secretion. This regulation is essential for host defense against intracellular pathogens and for preventing immunopathology. Researchers study GO:0032655 to understand how antigen-presenting cells integrate microbial and host-derived signals to calibrate IL-12 output, and how dysregulation contributes to autoimmunity, chronic infection, and cancer. The term includes both positive and negative regulation at transcriptional, post-transcriptional, and secretory levels.
regulation of interleukin-12 production At A Glance
| GO ID | GO:0032655 |
|---|---|
| GO term | regulation of interleukin-12 production |
| Ontology | biological_process |
| Synonym | regulation of CLMF production; regulation of IL-12 production; regulation of interleukin-12 biosynthetic process; regulation of interleukin-12 secretion; regulation of NKSF production |
| Major function | Modulates the frequency, rate, or extent of interleukin-12 production, thereby influencing Th1 immune responses |
| Primary cell types | Dendritic cells, macrophages, monocytes, and other antigen-presenting cells |
| Key positive regulators | TLR ligands, CD40, IFN-gamma, complement receptor 3 |
| Key negative regulators | IL-10, TGF-beta, SOCS1 |
| Disease relevance | Autoimmunity, chronic infections, cancer |
What Is GO:0032655?
GO:0032655 is defined as any process that modulates the frequency, rate, or extent of interleukin-12 production. This includes regulation of IL-12 biosynthetic process, secretion, and overall production, as well as the synonymous processes regulation of CLMF production and regulation of NKSF production.
Why Is regulation of interleukin-12 production Important in Cell Biology?
Regulation of IL-12 production is a critical checkpoint in immune responses because IL-12 dictates the balance between protective Th1 immunity and immunopathology. Understanding GO:0032655 helps explain how pathogens evade immunity, how autoimmune inflammation arises, and how to design immunotherapies that harness or suppress IL-12.
• Controls Th1 differentiation and cell-mediated immunity against intracellular pathogens.
• Dysregulated IL-12 production is linked to autoimmune diseases such as multiple sclerosis and inflammatory bowel disease.
• IL-12 is critical for tumor immunosurveillance and is used in experimental cancer immunotherapy.
• Negative regulation by IL-10 and SOCS1 prevents excessive inflammation and tissue damage.
• Differential regulation of IL-12 versus IL-23 influences Th17 responses and autoimmunity.
• Pathogens can subvert IL-12 production to establish chronic infection.
• Genetic variation in IL-12 pathway genes affects susceptibility to infectious and autoimmune diseases.
• IL-12 production is a biomarker for vaccine efficacy and adjuvant activity.
• CRISPR screens can identify novel regulators of IL-12 production in primary immune cells.
• The term provides a framework for integrating signaling, transcriptional, and secretory mechanisms.
What Happens During regulation of interleukin-12 production?
Recognition of microbial and host signals
In simple terms: Immune cells sense danger signals from microbes or the host, which triggers a decision to make IL-12.
Antigen-presenting cells detect pathogen-associated molecular patterns through Toll-like receptors (TLRs) and complement receptor 3 (CR3), leading to activation of NF-kB and other transcription factors that drive IL-12 transcription. Host-derived signals such as IFN-gamma and CD40 ligand also provide positive regulatory inputs.
Transcriptional and post-transcriptional control of IL-12 subunits
In simple terms: The genes for IL-12's two parts are turned on or off, and their RNA messages are stabilized or degraded.
IL-12 production requires coordinated expression of the p35 and p40 subunits, which are encoded by IL12A and IL12B, respectively. Transcription factors including NF-kB, IRF1, and IRF8 promote IL12B transcription, while negative regulators such as IL-10 and TGF-beta suppress it. Post-transcriptional mechanisms, including mRNA stability and microRNA targeting, further modulate IL-12 output.
Assembly and secretion of the IL-12 heterodimer
In simple terms: The two protein parts combine and are released from the cell as active IL-12.
The p35 and p40 subunits assemble into the biologically active p70 heterodimer in the endoplasmic reticulum and are secreted. Regulation of secretion can occur at the level of subunit pairing, glycosylation, and vesicular transport.
Negative feedback and resolution of IL-12 production
In simple terms: Once IL-12 is made, signals are shut off to prevent too much inflammation.
IL-12 production is self-limited by negative regulators such as IL-10, TGF-beta, and suppressor of cytokine signaling 1 (SOCS1). SOCS1 negatively regulates IL-12 signaling, thereby dampening further production. This feedback is essential to avoid chronic inflammation and tissue damage.
Integration with Th1/Th17 polarization
In simple terms: The amount of IL-12 helps decide whether immune cells become Th1 or Th17 types.
IL-12 promotes Th1 differentiation, while IL-23, which shares the p40 subunit, promotes Th17 responses. Differential regulation of IL-12 versus IL-23 production in dendritic cells determines the balance between these T helper subsets. This balance is critical for immunity to intracellular bacteria and fungi, and for autoimmunity.
Key Genes Involved in GO:0032655 regulation of interleukin-12 production
The following genes and proteins are central to the regulation of interleukin-12 production, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL12A | Encodes the p35 subunit of IL-12 | Essential for IL-12 heterodimer formation; knockout abolishes IL-12 production |
| IL12B | Encodes the p40 subunit shared with IL-23 | Target for modulating IL-12/IL-23 balance; knockout reduces Th1 and Th17 responses |
| IL12RB1 | IL-12 receptor beta 1 subunit | Mediates IL-12 signaling; mutations cause immunodeficiency |
| IL12RB2 | IL-12 receptor beta 2 subunit | Required for high-affinity IL-12 binding and signaling |
| TLR2 | Toll-like receptor 2 | Recognizes microbial ligands and induces IL-12 production |
| TLR4 | Toll-like receptor 4 | Responds to LPS and promotes IL-12 production |
| TLR9 | Toll-like receptor 9 | Recognizes CpG DNA and enhances IL-12 production |
| CD40 | Costimulatory receptor on antigen-presenting cells | Ligation by CD40L boosts IL-12 production |
| IFNG | Interferon gamma | Positive feedback regulator of IL-12 production |
| IL10 | Interleukin-10 | Potent negative regulator of IL-12 production |
| TGFB1 | Transforming growth factor beta 1 | Suppresses IL-12 production and promotes Th17 |
| SOCS1 | Suppressor of cytokine signaling 1 | Negatively regulates IL-12 signaling and production |
| NFKB1 | NF-kB p50 subunit | Transcription factor driving IL12B expression |
| IRF1 | Interferon regulatory factor 1 | Enhances IL-12 p35 transcription |
| IRF8 | Interferon regulatory factor 8 | Critical for IL-12 p40 expression in dendritic cells |
| CR3 | Complement receptor 3 | Signaling via CR3 regulates IL-12 production |
| STAT1 | Signal transducer and activator of transcription 1 | Mediates IFN-gamma-induced IL-12 regulation |
| GATA3 | Transcription factor | Can negatively regulate IL-12 production in certain contexts |
How Is regulation of interleukin-12 production Regulated?
Regulation of IL-12 production is controlled by a network of positive and negative signals. Positive regulators include TLR ligands, CD40-CD40L interactions, IFN-gamma, and complement receptor 3 signaling. Negative regulators include IL-10, TGF-beta, and SOCS1, which dampen IL-12 transcription and signaling. The balance between these signals determines the magnitude and duration of IL-12 production, influencing Th1/Th17 polarization.
regulation of interleukin-12 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL12B | Psoriasis, Crohn's disease | Knockout mice or human cell lines with IL12B deletion |
| IL12A | Celiac disease, multiple sclerosis | Point mutation knock-in to mimic risk variants |
| IL12RB1 | Mendelian susceptibility to mycobacterial disease | Patient-derived iPSCs with IL12RB1 mutations |
| SOCS1 | Autoimmunity, inflammation | SOCS1 knockout mice or overexpression cell lines |
| IL10 | Inflammatory bowel disease | IL10 knockout mice and human macrophage models |
Autoimmune and inflammatory diseases
Excessive IL-12 production promotes Th1-mediated autoimmunity, including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. Conversely, insufficient IL-12 signaling can impair immunity to intracellular pathogens.
Infectious diseases
IL-12 is essential for host defense against intracellular bacteria such as mycobacteria and Salmonella. Pathogens can evade immunity by suppressing IL-12 production.
Cancer
IL-12 enhances antitumor immunity by promoting Th1 responses and cytotoxic T cell activity. However, chronic IL-12 production can contribute to inflammation-associated carcinogenesis.
From regulation of interleukin-12 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene affect IL-12 production? | CRISPR knockout in primary dendritic cells or THP-1 cells |
| Does a specific SNP alter IL-12 regulation? | Point mutation knock-in using CRISPR in cell lines |
| Can a tagged IL-12 subunit be used to track secretion? | Knock-in of fluorescent or epitope tag at IL12A or IL12B locus |
| Does overexpression of a negative regulator suppress IL-12? | CRISPR activation or lentiviral overexpression |
| Which genes regulate IL-12 in a genome-wide manner? | CRISPR library screening with IL-12 readout |
| Can we model human IL-12 dysregulation in vivo? | Humanized mice engrafted with CRISPR-edited hematopoietic stem cells |
How to Study the regulation of interleukin-12 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted IL-12 p70/p40 protein levels | Quantify IL-12 production in supernatants |
| Luminex | Multiplex cytokine levels including IL-12 | Profile cytokine responses in immune cells |
| RNA-seq | Transcriptome including IL12A/IL12B mRNA | Identify transcriptional regulators |
| Intracellular cytokine staining | IL-12-producing cells by flow cytometry | Assess single-cell heterogeneity |
| CRISPR knockout screen | Genes affecting IL-12 production | Discover novel regulators |
| CRISPR activation screen | Genes whose overexpression enhances IL-12 | Identify positive regulators |
| Reporter knock-in | Real-time IL-12 promoter activity or secretion | Track dynamics in live cells |
| Bioinformatics pathway analysis | Enrichment of GO terms and pathways | Interpret screen hits in context of GO:0032655 |
Cytokine quantification assays
ELISA and Luminex are standard methods to measure IL-12 p70, p40, and p35 levels in culture supernatants and serum. These assays are used to assess the impact of genetic perturbations on IL-12 production.
Transcriptional profiling
RNA-seq and qPCR measure IL12A and IL12B mRNA levels, providing insights into transcriptional regulation. Single-cell RNA-seq can resolve heterogeneity in IL-12-producing cells.
Flow cytometry and imaging
Intracellular cytokine staining and fluorescent reporter knock-in models allow visualization of IL-12 production at single-cell resolution. Imaging can track secretion dynamics.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens coupled with IL-12 readouts identify novel regulators of GO:0032655. Bioinformatics analysis integrates screen hits with pathway databases.
How CRISPR Can Be Used to Study GO:0032655 regulation of interleukin-12 production
Knockout
CRISPR knockout of candidate genes such as IL12B, IL12A, or SOCS1 in antigen-presenting cells can definitively test their requirement for IL-12 production. Knockout models are also used in pooled screens to identify novel regulators.
Point Mutation
Point mutation knock-in can model human single-nucleotide polymorphisms in IL12B or IL12RB1 that affect IL-12 regulation and disease susceptibility. This approach allows precise allele-specific functional studies.
Knock-in
Knock-in of fluorescent tags, epitope tags, or Cre recombinase at the IL12A or IL12B locus enables tracking of IL-12 expression and secretion in real time. Knock-in of human IL12B into mouse models can humanize the IL-12 system.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of positive regulators (e.g., NFKB1, IRF1) or negative regulators (e.g., SOCS1, IL10) can modulate IL-12 production. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of interleukin-12 production Research
Researchers studying regulation of interleukin-12 production-related genes often need to determine whether a candidate gene is causally involved in modulating IL-12 levels, and to dissect the precise mechanisms by which genetic variants or expression changes alter immune responses. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-12 production research.
Frequently Asked Questions About regulation of interleukin-12 production
What is GO:0032655?
GO:0032655 is the Gene Ontology term for regulation of interleukin-12 production, defined as any process that modulates the frequency, rate, or extent of IL-12 production.
What genes are involved in regulation of interleukin-12 production?
Key genes include IL12A, IL12B, IL12RB1, IL12RB2, TLRs, CD40, IFNG, IL10, TGFB1, SOCS1, NFKB1, IRF1, and IRF8.
How is IL-12 production regulated in dendritic cells?
Dendritic cells regulate IL-12 production through pattern recognition receptors, CD40 signaling, and cytokines such as IFN-gamma and IL-10, which balance Th1 and Th17 responses.
What diseases are associated with dysregulated IL-12 production?
Dysregulated IL-12 production is associated with autoimmune diseases, chronic infections, and cancer.
What is the role of SOCS1 in IL-12 regulation?
SOCS1 negatively regulates IL-12 signaling and production, acting as a feedback inhibitor to prevent excessive inflammation.
How can CRISPR be used to study IL-12 regulation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes and variants in IL-12 production.
What is the difference between IL-12 and IL-23 regulation?
IL-12 and IL-23 share the p40 subunit but have distinct regulation; differential production influences Th1 versus Th17 polarization.
Which cytokines negatively regulate IL-12 production?
IL-10 and TGF-beta are major negative regulators of IL-12 production.
How is IL-12 production measured in the lab?
ELISA, Luminex, RNA-seq, flow cytometry, and reporter assays are commonly used to measure IL-12 production.
What cell types produce IL-12?
IL-12 is primarily produced by antigen-presenting cells including dendritic cells, macrophages, and monocytes.
Conclusion
GO:0032655 regulation of interleukin-12 production is a central immune regulatory process that determines the balance between protective Th1 immunity and immunopathology. Understanding its genetic and molecular control is essential for developing therapies for autoimmune diseases, infections, and cancer. CRISPR-based models provide powerful tools to dissect this regulation with precision.
References
- 1. Lyakh L et al.. 2008. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans.. Immunol Rev 226:112-31 PMID: 19161420
- 2. Ma X et al.. 2001. Regulation of interleukin-12 production in antigen-presenting cells.. Adv Immunol 79:55-92 PMID: 11680011
- 3. Wang Y et al.. 2012. The regulation and activity of interleukin-12.. Front Biosci (Schol Ed) 4(3):888-99 PMID: 22202097
- 4. Matsumoto M et al.. 2019. Elucidation of the Interleukin 12 Production Mechanism during Intracellular Bacterial Infection in Amberjack, Seriola dumerili.. Infect Immun 87(11) PMID: 31501250
- 5. Trinchieri G et al.. 1996. Immunoregulation by interleukin-12.. J Leukoc Biol 59(4):505-11 PMID: 8613697
- 6. Marth T et al.. 1997. Regulation of interleukin-12 by complement receptor 3 signaling.. J Exp Med 185(11):1987-95 PMID: 9166428
- 7. Gerosa F et al.. 2008. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells.. J Exp Med 205(6):1447-61 PMID: 18490488
- 8. Eyles JL et al.. 2002. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1.. J Biol Chem 277(46):43735-40 PMID: 12221108
